BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 14635071)

  • 21. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease.
    Irwin C; Levin W; Fyles A; Pintilie M; Manchul L; Kirkbride P
    Gynecol Oncol; 1998 Aug; 70(2):247-54. PubMed ID: 9740699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Keys HM; Roberts JA; Brunetto VL; Zaino RJ; Spirtos NM; Bloss JD; Pearlman A; Maiman MA; Bell JG;
    Gynecol Oncol; 2004 Mar; 92(3):744-51. PubMed ID: 14984936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
    Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
    Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
    Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
    Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced age is a significant determinant of poor prognosis in patients treated with surgery plus postoperative radiotherapy for endometrial cancer.
    Okuma K; Yamashita H; Kawana K; Nakagawa S; Oda K; Nakagawa K
    J Obstet Gynaecol Res; 2010 Aug; 36(4):757-63. PubMed ID: 20666941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
    Allal AS; Maire D; Becker M; Dulguerov P
    Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial carcinoma in patients aged 75 years or older: outcome and complications after postoperative radiotherapy or radiotherapy alone.
    Huguenin PU; Glanzmann C; Hammer F; Lütolf UM
    Strahlenther Onkol; 1992 Oct; 168(10):567-72. PubMed ID: 1440228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age as a prognostic factor for recurrence in patients with endometrial carcinoma.
    Mundt AJ; Waggoner S; Yamada D; Rotmensch J; Connell PP
    Gynecol Oncol; 2000 Oct; 79(1):79-85. PubMed ID: 11006036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined surgical and radiotherapy treatment in endometrial cancer].
    Del Pup L; Boz G; De Paoli A; Innocente R; Scozzari G; Scarabelli C; Trovò GM
    Minerva Ginecol; 1994 Oct; 46(10):535-43. PubMed ID: 7838409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women.
    Macdonald OK; Sause WT; Lee RJ; Lee CM; Dodson MK; Zempolich K; Gaffney DK
    Gynecol Oncol; 2006 Nov; 103(2):661-6. PubMed ID: 16797682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of pathologic Stage IIA endometrial adenocarcinoma after intravaginal brachytherapy alone.
    Siddiqui F; Ibrahim DR; Aref I; Lu M; Kim WS; Schultz D; Elshaikh MA
    Brachytherapy; 2009; 8(4):396-400. PubMed ID: 19733127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer].
    Lei X; Shan JL; Tang C; Zhao KW
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.